While some bankers (and even some Fools) would like to see executives at the likes of Goldman Sachs
Well, many of them, anyway.
Johnson & Johnson
And then there's Merck
Sometimes in investing, public relations are just as important as earnings -- especially during the bear market we are in.
Johnson & Johnson is a current pick of Motley Fool Income Investor; Pfizer and Bank of America are former recommendations of the newsletter. Pfizer is a Motley Fool Inside Value recommendation. Try any of our Foolish newsletters today, free for 30 days.